Novel Molecular Markers for Breast Cancer

The use of molecular biomarkers assures that breast cancer (BC) patients receive optimal treatment. Established biomarkers, such as estrogen receptor, progesterone receptor, HER2, and Ki67, have been playing significant roles in the subcategorization of BC to predict the prognosis and decide the spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Kazushi, Fry, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790586/
https://www.ncbi.nlm.nih.gov/pubmed/26997872
http://dx.doi.org/10.4137/BIC.S38394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790586/
https://www.ncbi.nlm.nih.gov/pubmed/26997872
http://dx.doi.org/10.4137/BIC.S38394

Ejemplares similares